RecruitingNCT07659769
Global Healthcare Study on Hidradenitis Suppurativa
Sponsor
Julia Tatjana Maul
Enrollment
9,600 participants
Start Date
Jan 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The Global Healthcare Study on Hidradenitis Suppurativa (GHSHS) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with psoriasis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Eligibility
Min Age: 14 Years
Inclusion Criteria2
- Signed General Consent Form, or equivalent document
- Confirmed diagnosis of Hidradenitis Suppurativa
Exclusion Criteria2
- Inability to provide informed consent.
- Datasets with ambiguous or unclear diagnosis.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07659769
Related Trials
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
NCT0721397330 locations
Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
NCT074895737 locations
The Safety and Efficacy of Roflumilast Foam in HS
NCT072632301 location
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
NCT06855498316 locations
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
NCT0728764458 locations